KALA BIO, Inc. (KALA)
NASDAQ·Healthcare·Biotechnology
$0.11
-4.44%
Mkt Cap $5.69M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 15, 2026 | — | — | — | -$0.17 | $0.86 | +605.88% | — | — |
| Q4 2025 Nov 19, 2025 | — | — | — | -$1.01 | -$1.07 | -5.94% | — | — |
| Q3 2025 Aug 8, 2025 | — | — | — | -$1.82 | -$1.71 | +6.04% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$2.03 | -$1.41 | +30.54% | — | — |
| Q1 2025 Mar 31, 2025 | — | $254.00K | — | -$2.28 | -$1.74 | +23.68% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$2.43 | -$1.93 | +20.58% | — | — |
| Q3 2024 Aug 6, 2024 | — | — | — | -$4.41 | -$3.16 | +28.34% | — | — |
| Q2 2024 May 14, 2024 | — | — | — | -$2.89 | -$4.20 | -45.33% | — | — |
| Q1 2024 Mar 29, 2024 | — | $70.00K | — | -$3.62 | -$3.18 | +12.15% | — | — |
| Q4 2023 Nov 13, 2023 | $2.50M | — | — | -$2.15 | -$3.41 | -58.60% | — | — |
| Q3 2023 Aug 4, 2023 | — | — | — | -$3.19 | -$4.36 | -36.68% | — | — |
| Q2 2023 May 9, 2023 | — | — | — | -$5.10 | -$6.99 | -37.06% | — | — |
| Q1 2023 Mar 3, 2023 | — | $1.23M | — | -$6.56 | -$7.97 | -21.49% | — | — |
| Q4 2022 Nov 8, 2022 | $62.50M | $420.00K | -99.33% | $10.75 | $19.25 | +79.07% | — | — |
| Q3 2022 Aug 11, 2022 | $2.02M | $2.10M | +4.05% | -$22.00 | -$19.00 | +13.64% | — | — |
| Q2 2022 May 16, 2022 | $3.11M | $1.37M | -55.82% | -$18.00 | -$22.50 | -25.00% | — | — |
| Q1 2022 Mar 29, 2022 | $3.38M | $1.86M | -45.07% | -$21.50 | -$34.00 | -58.14% | — | — |
| Q4 2021 Nov 15, 2021 | $5.31M | $3.07M | -42.24% | -$22.50 | -$21.50 | +4.44% | — | — |
| Q3 2021 Aug 5, 2021 | $5.25M | $3.05M | -41.89% | -$22.00 | -$28.50 | -29.55% | — | — |
| Q2 2021 May 5, 2021 | $4.18M | $3.27M | -21.84% | -$25.50 | -$24.50 | +3.92% | — | — |